The Impact of Different Anesthetics on the Distribution and Cytotoxic Function of NK Cell Subpopulations: An In Vitro Study.
Humans
Killer Cells, Natural
/ drug effects
Adult
Male
Sevoflurane
/ pharmacology
Anesthetics
/ pharmacology
Lidocaine
/ pharmacology
Propofol
/ pharmacology
Female
Leukocytes, Mononuclear
/ drug effects
Dexmedetomidine
/ pharmacology
Cytotoxicity, Immunologic
/ drug effects
CD56 Antigen
/ metabolism
Flow Cytometry
Remifentanil
/ pharmacology
immunology
lidocaine
natural killer cells
propofol
sevoflurane
total intravenous anesthesia
volatile anesthetics
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
14 Oct 2024
14 Oct 2024
Historique:
received:
02
09
2024
revised:
30
09
2024
accepted:
10
10
2024
medline:
26
10
2024
pubmed:
26
10
2024
entrez:
26
10
2024
Statut:
epublish
Résumé
Only some subpopulations of natural killer (NK) cells have cytotoxic functionality, and the effects of anesthetics on these subpopulations are unknown. This study aimed to evaluate the in vitro effects of various anesthetics, both alone and in combination, on the distribution and cytotoxic function of NK cells and their subpopulations. Peripheral blood mononuclear cells (PBMCs) from eight healthy volunteers were treated for 4 h in vitro with dexmedetomidine, remifentanil, lidocaine, propofol, sevoflurane, and combinations in clinically relevant concentrations or left untreated. Flow cytometry was used to quantify the percentage of sampled NK cells and evaluate their distribution (CD56
Identifiants
pubmed: 39456827
pii: ijms252011045
doi: 10.3390/ijms252011045
pii:
doi:
Substances chimiques
Sevoflurane
38LVP0K73A
Anesthetics
0
Lidocaine
98PI200987
Propofol
YI7VU623SF
Dexmedetomidine
67VB76HONO
CD56 Antigen
0
Remifentanil
P10582JYYK
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
Tristan J. Vulcano: No conflicts of interest to report. Wayel H. Abdulahad: No conflicts of interest to report. Matijs van Meurs: No conflicts of interest to report. Rianne M. Jongman: No conflicts of interest to report. Michel M.R.F. Struys: The author has no conflicts of interest related to this manuscript. In general, his research group/department received (over the last 3 years) research grants and consultancy fees from Masimo (Irvine, CA, USA), Becton Dickinson (Eysins, Switzerland), Fresenius (Bad Homburg, Germany), Paion (Aachen, Germany), Medcaptain Europe (Andelst, The Netherlands), Baxter (Chicago, Il, USA), and HanaPharm (Seoul, Republic of Korea). He receives royalties on intellectual property from Demed Medical (Sinaai, Belgium) and Ghent University (Gent, Belgium). Dirk J. Bosch: No conflicts of interest to report.